Skip to content
MedCompare

Epoetin Alfa

Save $4,831/mo
10× cheaper

Epogen is an erythropoiesis-stimulating agent (ESA) indicated for: Treatment of anemia due to: - Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis ( 1.1 ).

United States
$5,383
per month
India
$552
per month
You save
$4,831
90% cheaper in India
122.9K US scripts/yr$593.9M potential annual savings$661.7M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC42H73NO16

SMILES: C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CCO)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)O)(C)O

Compare the price
US price$5,383per month
India price$552per month
You save$4,83190% less

Based on 30 units per month. US $179.43 vs India $18.39 per unit.

Total over 1 periodSave $4,831$5,383 → $552
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$28,987
Estimated travel cost
− $2,300
Net savings after travel
$26,687

Even after travel, you could come out ahead by about $26,687.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Epoetin Alfa is filled about 122.9K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$661.7M
If sourced from India
$67.8M
Potential annual savings
$593.9M
−90%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.